Ranbaxy Laboratories Ltd.

Ranbaxy Laboratories Ltd.

• Drug manufacturer agrees to $500 million penalty

  A subsidiary of India's largest pharmaceutical company has agreed to pay a record $500 million in fines and penalties for selling adulterated drugs ... 

• Drugmaker Ranbaxy halts generic Lipitor production

  Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles ... 

• Ranbaxy recalls generic Lipitor doses

  Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass ...